Aktie 6499 MEDEON BIODESIGN, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Medeon Biodesign, Inc.

Aktien

6499

TW0006499007

6499

Schlusskurs Taipei Exchange
Andere Börsenplätze
 00:00:00 03.05.2024 		% 5 Tage % 1. Jan.
42,55 TWD +0,12 % Intraday Chart für Medeon Biodesign, Inc. -0,23 % -8,79 %
08.03. Medeon Biodesign, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Medeon Biodesign, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Medeologix Inc. announced that it expects to receive TWD 315 million in funding from Medeon Biodesign, Inc.
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Medeon Biodesign, Inc.(TPEX:6499) added to S&P Global BMI Index
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 6499 Aktie
  4. Nachrichten Medeon Biodesign, Inc.
  5. Andere Sprachen